Intranasal COVID-19 Vaccine Works Against COVID-19 Variants

Although India has approved intranasal COVID vaccines in recent months, the road to formulating successful intranasal vaccines is not an easy one.

Researchers have discovered a COVID nasal vaccine that is effective against original COVID virus and two variants in hamsters.

The current batch of injected COVID vaccines have been effective at combating SARS-CoV-2 infection around the globe. But these shots enter the body in the muscle tissue, whereas the virus enters and causes many of the typical COVID symptoms in the respiratory tract.

Effectiveness of Intranasal COVID Vaccination

Thus, intranasal immunizations with a spray or droplets could be a better option.

COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.

TOP INSIGHT

An intranasal vaccine against SARS-CoV-2 could quickly get to the respiratory tract, where the virus most commonly causes symptoms. And a spray or droplets could be a more palatable option for people who fear needles.

For example, AstraZeneca announced this month that its intranasal candidate failed to produce a strong immune response in nasal tissues and offered less systemic protection than the intramuscular version. So, Madhavan Nallani, Pierre Vandepapeliere and colleagues wanted to formulate an intranasal COVID vaccine that would stimulate an immune response both systemically and in the respiratory tract, and that would also work against SARS-CoV-2 variants.

The researchers based their vaccine on the spike protein from the SARS-CoV-2 beta variant, separately encapsulating the antigen and an immune-stimulating adjuvant into nanoparticles known as artificial cell membrane polymersomes. They packaged the two components separately so that they could more easily change the spike component to one from another variant if needed. Intramuscular co-administration of the parts produced a strong immune response in both mice and hamsters.

When the hamsters injected with the new vaccine were exposed to live virus, however, they still developed an infection. In contrast, intranasal coadministration in hamsters produced a strong systemic immune response. It also cleared viruses from the respiratory tract and prevented infection-associated lung damage. Regardless of how the vaccine was administered, it provided protection against multiple variants, including omicron. Based on these results, the researchers are now recruiting participants for a Phase 1 clinical trial.

COVID-19 Vaccine: Myths and Facts
Debunking several misconceptions or myths that have surfaced regarding covid vaccination is important and focus on the facts related to COVID-19 vaccines.

The authors acknowledge funding by the National Health Innovation Centre Gap Funding Award Singapore.

Source-Eurekalert

What are the Most Common Lingering COVID-19 Symptoms?
Long COVID-19 symptoms can be avoided by getting vaccinated or boosted to help protect your brain and body.

Can Booster Dose Prevent Covid-19 Infection?
Three-dose mRNA regimen, be it heterologous and homologous, is found to be the most effective in preventing Covid-19 infections.